RhumbLine Advisers’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-49,352
Closed -$8.49M 3047
2021
Q3
$8.49M Sell
49,352
-762
-2% -$131K 0.01% 1052
2021
Q2
$6.29M Sell
50,114
-2,955
-6% -$371K 0.01% 1297
2021
Q1
$7.2M Sell
53,069
-4,032
-7% -$547K 0.01% 1200
2020
Q4
$7.31M Sell
57,101
-779
-1% -$99.7K 0.01% 1123
2020
Q3
$6.51M Buy
57,880
+1,756
+3% +$198K 0.01% 1000
2020
Q2
$5.35M Sell
56,124
-14,952
-21% -$1.42M 0.01% 1174
2020
Q1
$6.39M Buy
71,076
+1,540
+2% +$138K 0.01% 893
2019
Q4
$3.69M Buy
69,536
+2,300
+3% +$122K 0.01% 1444
2019
Q3
$2.66M Buy
67,236
+2,186
+3% +$86.4K ﹤0.01% 1573
2019
Q2
$2.67M Buy
65,050
+5,937
+10% +$244K 0.01% 1563
2019
Q1
$2.75M Buy
59,113
+5,779
+11% +$269K 0.01% 1525
2018
Q4
$2.32M Buy
53,334
+16,757
+46% +$730K 0.01% 1549
2018
Q3
$2.09M Sell
36,577
-1,545
-4% -$88.4K ﹤0.01% 1632
2018
Q2
$1.85M Buy
38,122
+1,268
+3% +$61.5K ﹤0.01% 1714
2018
Q1
$1.44M Sell
36,854
-630
-2% -$24.6K ﹤0.01% 1781
2017
Q4
$1.59M Sell
37,484
-1,048
-3% -$44.5K ﹤0.01% 1747
2017
Q3
$1.44M Buy
38,532
+1,315
+4% +$49.1K ﹤0.01% 1799
2017
Q2
$1.13M Buy
37,217
+4,945
+15% +$150K ﹤0.01% 1888
2017
Q1
$854K Buy
32,272
+1,284
+4% +$34K ﹤0.01% 1999
2016
Q4
$791K Buy
30,988
+3,454
+13% +$88.2K ﹤0.01% 1976
2016
Q3
$996K Buy
27,534
+500
+2% +$18.1K ﹤0.01% 1805
2016
Q2
$919K Buy
27,034
+3,441
+15% +$117K ﹤0.01% 1836
2016
Q1
$623K Buy
23,593
+2,950
+14% +$77.9K ﹤0.01% 2064
2015
Q4
$1.01M Buy
20,643
+1,475
+8% +$72K ﹤0.01% 1798
2015
Q3
$477K Buy
19,168
+483
+3% +$12K ﹤0.01% 2254
2015
Q2
$591K Buy
18,685
+3,215
+21% +$102K ﹤0.01% 2222
2015
Q1
$589K Buy
15,470
+2,700
+21% +$103K ﹤0.01% 2197
2014
Q4
$498K Sell
12,770
-550
-4% -$21.4K ﹤0.01% 2283
2014
Q3
$403K Sell
13,320
-500
-4% -$15.1K ﹤0.01% 2350
2014
Q2
$469K Buy
+13,820
New +$469K ﹤0.01% 2316